Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Multiple Sclerosis

Free Subscription Articles published in PLoS One Retrieve available abstracts of 79 articles: HTML format

Single Articles

January 2025
1. SIEBALD F, Grittner U, Otto C, Bereuter C, et al
   Ultrasound pupillometry for the detection of a relative afferent pupillary defect (RAPD): Systematic evaluation in patients with optic neuritis and comparison with infrared video pupillometry.
   PLoS One. 2025;20:e0315712.
   PubMed     Abstract available
   
   
   
2. VAN REENEN EC, van Nistelrooij IAM, Visser LH, de Beukelaar JWK, et al
   The liminal space between hope and grief: The phenomenon of uncertainty as experienced by people living with relapsing-remitting multiple sclerosis.
   PLoS One. 2025;20:e0315501.
   PubMed     Abstract available
   
   
   
3. JAALKHOROL M, Dashtseren A, Magnaibayar G, Bat-Orgil B, et al
   Factors associated with vitamin D levels in Mongolian patients with multiple sclerosis.
   PLoS One. 2025;20:e0317279.
   PubMed     Abstract available
   
   
   
4. COSTA V, Aluan K, Schiavetti I, Bason C, et al
   Study protocol: Exploratory trial of Forza, an osmotin-based nutraceutical as adjuvant for the treatment of progressive multiple sclerosis.
   PLoS One. 2025;20:e0311214.
   PubMed     Abstract available
   
   
   
5. KHDAIR SI, Al-Khareisha L, Abusara OH, Hammad AM, et al
   HLA-class II genes association with multiple sclerosis: An immunogenetic prediction among multiple sclerosis Jordanian patients.
   PLoS One. 2025;20:e0318824.
   PubMed     Abstract available
   
   
   
6. DE DIOS PEREZ B, Booth V, das Nair R, Evangelou N, et al
   Vocational rehabilitation for people with multiple sclerosis in the national health service of the United Kingdom: A realist evaluation.
   PLoS One. 2025;20:e0319287.
   PubMed     Abstract available
   
   
   
7. RUSSO JS, Mahoney T, Kokorin K, Reynolds A, et al
   Towards developing brain-computer interfaces for people with Multiple Sclerosis.
   PLoS One. 2025;20:e0319811.
   PubMed     Abstract available
   
   
   
8. ETEMADIFAR M, Shoeib S, Salari M, Etemadifar M, et al
   Gynecologic health of women with multiple sclerosis: An overview on the current status and findings of Pap tests in a low-income setting.
   PLoS One. 2025;20:e0320069.
   PubMed     Abstract available
   
   
   
9. GOETTFRIED E, Barket R, Hershman R, Delazer M, et al
   Face exploration, emotion recognition, and emotional enhancement of memory in relapsing-remitting multiple sclerosis.
   PLoS One. 2025;20:e0319967.
   PubMed     Abstract available
   
   
   
10. SCHLAEGER S, Muhlau M, Gilbert G, Vavasour I, et al
    Sensitivity of multi-parametric quantitative magnetic resonance imaging for multiple sclerosis pathology.
    PLoS One. 2025;20:e0318415.
    PubMed     Abstract available
    
    
    
11. ZANGENEH Z, Rostamian M, Motamedi H, Alvandi A, et al
    The potential effectiveness of probiotics in reducing multiple sclerosis progression in preclinical and clinical studies: A worldwide systematic review and meta-analysis.
    PLoS One. 2025;20:e0319755.
    PubMed     Abstract available
    
    
    
12. OMER N, Wilczynski E, Zlotzover S, Helft C, et al
    Validation of a data-driven multicomponent T2 analysis for quantifying myelin content in the cuprizone mouse model of multiple sclerosis.
    PLoS One. 2025;20:e0323614.
    PubMed     Abstract available
    
    
    
13. YOUNG G, Nguyen VS, Howlett-Prieto Q, Abuaf AF, et al
    Validation of retroactively derived T1 relaxation values from 3D T1-weighted images with clinical and MRI measures of disability in multiple sclerosis.
    PLoS One. 2025;20:e0323898.
    PubMed     Abstract available
    
    
    
14. OZTURK HK, Slanar O, Michalickova D
    Safety and efficacy of antigen-specific therapeutic approaches for multiple sclerosis: Systematic review.
    PLoS One. 2025;20:e0320814.
    PubMed     Abstract available
    
    
    
15. DE DIOS PEREZ B, Kendrick D, das Nair R, Evangelou N, et al
    Optimising access to vocational rehabilitation through multiple sclerosis charities: Protocol for a feasibility randomised controlled trial.
    PLoS One. 2025;20:e0325570.
    PubMed     Abstract available
    
    
    
16. GONG X, Xue X, Gao R, Feng S, et al
    Application of telemedicine in fatigue management for patients with multiple sclerosis: A scoping review.
    PLoS One. 2025;20:e0327563.
    PubMed     Abstract available
    
    
    
17. MIRMOSAYYEB O, Vaheb S, Afshari-Safavi A, Shaygannejad A, et al
    Long-term effects of air pollution on the incidence and progression of multiple sclerosis: A population cohort study in Isfahan, Iran.
    PLoS One. 2025;20:e0327635.
    PubMed     Abstract available
    
    
    
18. AL-EITAN L, Darabseh S
    VDR gene variants FokI and ApaI: Factors associated with susceptibility to multiple sclerosis.
    PLoS One. 2025;20:e0332473.
    PubMed     Abstract available
    
    
    
19. LI L, Olcer M, Wang Z, Song Y, et al
    IFN-beta therapy rescues dysregulated IFN-stimulated proteins, serum cytokines, and neurotrophic factors in multiple sclerosis: Multiplex analysis of short-term and long-term IFN responses.
    PLoS One. 2025;20:e0330867.
    PubMed     Abstract available
    
    
    
20. AL-EITAN L, Ataa A
    Investigating genetic links of vitamin D metabolism pathway genes (CYP2R1, CYP27B1, CYP24A1, and DBP) in Multiple Sclerosis patients.
    PLoS One. 2025;20:e0333924.
    PubMed     Abstract available
    
    
    
21. SOLARI A, De Panfilis L, Zagarella RM, Ghirotto L, et al
    Advance care planning in multiple sclerosis (ConCure-SM): A multicenter single-arm pilot and feasibility study.
    PLoS One. 2025;20:e0331220.
    PubMed     Abstract available
    
    
    
22. SHEMIRANI F, Pingel WR, Titcomb TJ, Salari-Moghaddam A, et al
    Correction: The effect of dietary interventions on inflammatory biomarkers among people with multiple sclerosis: A protocol for systematic review and meta-analysis of randomized controlled trials.
    PLoS One. 2025;20:e0334893.
    PubMed     Abstract available
    
    
    January 2024
23. TOLF A, Gauffin H, Burman J, Landtblom AM, et al
    Experiences of being treated with autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: A qualitative interview study.
    PLoS One. 2024;19:e0297573.
    PubMed     Abstract available
    
    
    
24. SHEMIRANI F, Pingel WR, Titcomb TJ, Salari-Moghaddam A, et al
    The effect of dietary interventions on inflammatory biomarkers among people with multiple sclerosis: A protocol for systematic review and meta-analysis of randomized controlled trials.
    PLoS One. 2024;19:e0297510.
    PubMed     Abstract available
    
    
    
25. DADVAR A, Jameie M, Azizmohammad Looha M, Parsaei M, et al
    Potential efficacy of caffeine ingestion on balance and mobility in patients with multiple sclerosis: Preliminary evidence from a single-arm pilot clinical trial.
    PLoS One. 2024;19:e0297235.
    PubMed     Abstract available
    
    
    
26. JOZEF M, Locatelli I, Brecl Jakob G, Savsek L, et al
    Psychometric evaluation of the 5-item Medication Adherence Report Scale questionnaire in persons with multiple sclerosis.
    PLoS One. 2024;19:e0294116.
    PubMed     Abstract available
    
    
    
27. LIU Z, Fan T, Mo X, Kan J, et al
    Association between multiple sclerosis and cancer risk: A two-sample Mendelian randomization study.
    PLoS One. 2024;19:e0298271.
    PubMed     Abstract available
    
    
    
28. CARATIS F, Opielka M, Hausmann M, Velasco-Estevez M, et al
    The proton-sensing receptors TDAG8 and GPR4 are differentially expressed in human and mouse oligodendrocytes: Exploring their role in neuroinflammation and multiple sclerosis.
    PLoS One. 2024;19:e0283060.
    PubMed     Abstract available
    
    
    
29. LEREIM RR, Nytrova P, Guldbrandsen A, Havrdova EK, et al
    Natalizumab promotes anti-inflammatory and repair effects in multiple sclerosis.
    PLoS One. 2024;19:e0300914.
    PubMed     Abstract available
    
    
    
30. BRNABIC AJM, Curtis SE, Johnston JA, Lo A, et al
    Incidence of type 2 diabetes, cardiovascular disease and chronic kidney disease in patients with multiple sclerosis initiating disease-modifying therapies: Retrospective cohort study using a frequentist model averaging statistical framework.
    PLoS One. 2024;19:e0300708.
    PubMed     Abstract available
    
    
    
31. IMRAISH A, Abu Thiab T, Alsalem M, Dahbour S, et al
    The neuroprotective effect of human primary astrocytes in multiple sclerosis: In vitro model.
    PLoS One. 2024;19:e0300203.
    PubMed     Abstract available
    
    
    
32. KAMPAITE A, Gustafsson R, York EN, Foley P, et al
    Brain connectivity changes underlying depression and fatigue in relapsing-remitting multiple sclerosis: A systematic review.
    PLoS One. 2024;19:e0299634.
    PubMed     Abstract available
    
    
    
33. YAGHOOBPOOR S, Fathi M, Vakili K, Sayehmiri F, et al
    Insulin-like growth factor-1 (IGF-1) levels in multiple sclerosis patients: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0297091.
    PubMed     Abstract available
    
    
    
34. LOMER NB, Asalemi KA, Saberi A, Sarlak K, et al
    Predictors of multiple sclerosis progression: A systematic review of conventional magnetic resonance imaging studies.
    PLoS One. 2024;19:e0300415.
    PubMed     Abstract available
    
    
    
35. HARRISON DM, Allette YM, Zeng Y, Cohen A, et al
    Meningeal contrast enhancement in multiple sclerosis: Assessment of field strength, acquisition delay, and clinical relevance.
    PLoS One. 2024;19:e0300298.
    PubMed     Abstract available
    
    
    
36. BALDASSO BD, Raza SZ, Islam SS, Burry IB, et al
    Disrupted hemodynamic response within dorsolateral prefrontal cortex during cognitive tasks among people with multiple sclerosis-related fatigue.
    PLoS One. 2024;19:e0303211.
    PubMed     Abstract available
    
    
    
37. STEFANOVIC M, Jovanovic I, Zivkovic M, Stankovic A, et al
    Pathway analysis of peripheral blood CD8+ T cell transcriptome shows differential regulation of sphingolipid signaling in multiple sclerosis and glioblastoma.
    PLoS One. 2024;19:e0305042.
    PubMed     Abstract available
    
    
    
38. LI L, Zhang M, Gu M, Li J, et al
    The causal relationship between autoimmune diseases and age-related macular degeneration: A two-sample mendelian randomization study.
    PLoS One. 2024;19:e0303170.
    PubMed     Abstract available
    
    
    
39. CAMPANIONI S, Veiga C, Prieto-Gonzalez JM, Gonzalez-Novoa JA, et al
    Explainable machine learning on baseline MRI predicts multiple sclerosis trajectory descriptors.
    PLoS One. 2024;19:e0306999.
    PubMed     Abstract available
    
    
    
40. LI B, Zhang L, Li Q, Zhang J, et al
    Multiple sclerosis and abnormal spermatozoa: A bidirectional two-sample mendelian randomization study.
    PLoS One. 2024;19:e0308815.
    PubMed     Abstract available
    
    
    
41. KAKUCS Z, Illes Z, Hayden Z, Berki T, et al
    Osteopontin predicts late-time salience network-related functional connectivity in multiple sclerosis.
    PLoS One. 2024;19:e0309563.
    PubMed     Abstract available
    
    
    
42. SOKRATOUS D, Charalambous CC, Zamba-Papanicolaou E, Michailidou K, et al
    A 12-week in-phase bilateral upper limb exercise protocol promoted neuroplastic and clinical changes in people with relapsing remitting multiple sclerosis: A registered report randomized single-case concurrent multiple baseline study.
    PLoS One. 2024;19:e0299611.
    PubMed     Abstract available
    
    
    
43. SABOYA-GALINDO P, Mejia-Salgado G, Cifuentes-Gonzalez C, Rodriguez-Rodriguez CA, et al
    Uveitis characteristics and multiple sclerosis phenotype of patients with multiple sclerosis-associated uveitis: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0307455.
    PubMed     Abstract available
    
    
    
44. TISELL A, Soderberg K, Link Y, Lundberg P, et al
    Diffuse white matter pathology in multiple sclerosis during treatment with dimethyl fumarate-An observational study of changes in normal-appearing white matter using proton magnetic resonance spectroscopy.
    PLoS One. 2024;19:e0309547.
    PubMed     Abstract available
    
    
    
45. FABER W, Stillebroer AB
    Addressing bladder and bowel challenges in dutch multiple sclerosis patients: Symptom prevalence and patient referral pathways.
    PLoS One. 2024;19:e0310691.
    PubMed     Abstract available
    
    
    
46. NAFARI A, Vaheb S, Afshari-Safavi A, Ravankhah Z, et al
    Cancer and mortality risks among people with multiple sclerosis: A population-based study in Isfahan, Iran.
    PLoS One. 2024;19:e0312707.
    PubMed     Abstract available
    
    
    
47. IAQUINTO S, Ineichen BV, Salmen A, Kuhle J, et al
    Factors associated with low health-related quality of life in persons with multiple sclerosis: A quantile-based segmentation approach.
    PLoS One. 2024;19:e0312486.
    PubMed     Abstract available
    
    
    
48. MARIC GD, Pekmezovic TD, Tamas OS, Veselinovic ND, et al
    Investigation of differences between chronological and vascular age in persons with multiple sclerosis.
    PLoS One. 2024;19:e0311117.
    PubMed     Abstract available
    
    
    
49. SANTISTEBAN L, Teremetz M, Irazusta J, Lindberg PG, et al
    Correction: Outcome measures used in trials on gait rehabilitation in multiple sclerosis: A systematic literature review.
    PLoS One. 2024;19:e0314427.
    PubMed     Abstract available
    
    
    
50. NAJMI EA, Mirzaasgari Z, Motamed MR, Aslani A, et al
    Carotid intima-media thickness and risk of atherosclerosis in multiple sclerosis: A cross-sectional study.
    PLoS One. 2024;19:e0314031.
    PubMed     Abstract available
    
    
    
51. ZURRER WE, Cannon AE, Ewing E, Bruschweiler D, et al
    STEED: A data mining tool for automated extraction of experimental parameters and risk of bias items from in vivo publications.
    PLoS One. 2024;19:e0311358.
    PubMed     Abstract available
    
    
    
52. MIRMOSAYYEB O, Yazdan Panah M, Mokary Y, Mohammadi M, et al
    Neuroimaging markers and disability scales in multiple sclerosis: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0312421.
    PubMed     Abstract available
    
    
    
53. RASOULI S, Dakkali MS, Ghazvini A, Azarbad R, et al
    Predictive model for converting optic neuritis to multiple sclerosis; decision tree in focus.
    PLoS One. 2024;19:e0309702.
    PubMed     Abstract available
    
    
    
54. SHRIWASH N, Aiman A, Singh P, Basir SF, et al
    Understanding the role of potential biomarkers in attenuating multiple sclerosis progression via multiomics and network-based approach.
    PLoS One. 2024;19:e0314428.
    PubMed     Abstract available
    
    
    
55. KOOSHKI A, Farmani R, Amirabadizadeh A, Mehrpour O, et al
    Essential and toxic metal concentrations in biological samples of multiple sclerosis patients: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0313851.
    PubMed     Abstract available
    
    
    
56. BIGDELI A, Ghaderi-Zefrehei M, Lesch BJ, Behmanesh M, et al
    Bioinformatics analysis of myelin-microbe interactions suggests multiple types of molecular mimicry in the pathogenesis of multiple sclerosis.
    PLoS One. 2024;19:e0308817.
    PubMed     Abstract available
    
    
    January 2023
57. SOKRATOUS D, Charalambous CC, Papanicolaou EZ, Michailidou K, et al
    Investigation of in-phase bilateral exercise effects on corticospinal plasticity in relapsing remitting multiple sclerosis: A registered report single-case concurrent multiple baseline design across five subjects.
    PLoS One. 2023;18:e0272114.
    PubMed     Abstract available
    
    
    
58. ERSOY T, Hocaoglu E
    A 3-DoF robotic platform for the rehabilitation and assessment of reaction time and balance skills of MS patients.
    PLoS One. 2023;18:e0280505.
    PubMed     Abstract available
    
    
    
59. SEDIGHI B, Haghdoost A, Jangipour Afshar P, Abna Z, et al
    Multiple sclerosis and COVID-19: A retrospective study in Iran.
    PLoS One. 2023;18:e0283538.
    PubMed     Abstract available
    
    
    
60. LAICHINGER K, Bombach P, Dunschede J, Ruschil C, et al
    No evidence of oligoclonal bands, intrathecal immunoglobulin synthesis and B cell recruitment in acute ischemic stroke.
    PLoS One. 2023;18:e0283476.
    PubMed     Abstract available
    
    
    
61. ZAFEIRI L, Akerfeldt T, Tolf A, Carlson K, et al
    Anti-Mullerian hormone and pregnancy after autologous hematopoietic stem cell transplantation for multiple sclerosis.
    PLoS One. 2023;18:e0284288.
    PubMed     Abstract available
    
    
    
62. BENINI S, Pellegrini E, Descovich C, Lugaresi A, et al
    Burden and resources in caregivers of people with multiple sclerosis: A qualitative study.
    PLoS One. 2023;18:e0265297.
    PubMed     Abstract available
    
    
    
63. STAHL D, Friberg E
    Formal help for persons with multiple sclerosis-Background factors associated with usage of personal assistance and home help in Sweden.
    PLoS One. 2023;18:e0286010.
    PubMed     Abstract available
    
    
    
64. EVEREST E, Uygunoglu U, Tutuncu M, Bulbul A, et al
    Prospective outcome analysis of multiple sclerosis cases reveals candidate prognostic cerebrospinal fluid markers.
    PLoS One. 2023;18:e0287463.
    PubMed     Abstract available
    
    
    
65. GOODIN DS, Khankhanian P, Gourraud PA, Vince N, et al
    Multiple sclerosis: Exploring the limits and implications of genetic and environmental susceptibility.
    PLoS One. 2023;18:e0285599.
    PubMed     Abstract available
    
    
    
66. ESCHWEILER M, McCrum C, Giannouli E
    A registered report of a crossover study on the effects of face masks on walking adaptability in people with Parkinson's disease and multiple sclerosis.
    PLoS One. 2023;18:e0286402.
    PubMed     Abstract available
    
    
    
67. VILADES E, Cordon B, Perez-Velilla J, Orduna E, et al
    Evaluation of multiple sclerosis severity using a new OCT tool.
    PLoS One. 2023;18:e0288581.
    PubMed     Abstract available
    
    
    
68. NAISBY J, Wilson-Menzfeld G, Baker K, Morris R, et al
    Yoga and Multiple Sclerosis: Maintaining engagement in physical activity.
    PLoS One. 2023;18:e0288319.
    PubMed     Abstract available
    
    
    
69. FRAGKIADAKI E, Cotterill N, Rice C, Smith JA, et al
    Evaluation of the feasibility and acceptability of an integrative group psychological intervention for people with Multiple Sclerosis: A study protocol.
    PLoS One. 2023;18:e0288295.
    PubMed     Abstract available
    
    
    
70. RAZIA R, Majeed F, Amin R, Mukhtar S, et al
    Predictive value of alpha-synuclein expression in peripheral blood of multiple sclerosis patients: A two-dimensional assessment of a selected biomarker.
    PLoS One. 2023;18:e0285022.
    PubMed     Abstract available
    
    
    
71. MACHADO A, Azad A, Pettersson E, Hillert J, et al
    Gender differences in earnings among people with multiple sclerosis and associations with type of occupation and family composition: A population-based study with matched references.
    PLoS One. 2023;18:e0288998.
    PubMed     Abstract available
    
    
    
72. MEIJBOOM R, York EN, Kampaite A, Harris MA, et al
    Patterns of brain atrophy in recently-diagnosed relapsing-remitting multiple sclerosis.
    PLoS One. 2023;18:e0288967.
    PubMed     Abstract available
    
    
    
73. HERNANDEZ M, Ramon-Julvez U, Vilades E, Cordon B, et al
    Explainable artificial intelligence toward usable and trustworthy computer-aided diagnosis of multiple sclerosis from Optical Coherence Tomography.
    PLoS One. 2023;18:e0289495.
    PubMed     Abstract available
    
    
    
74. HARRIS VK, Wollowitz J, Greenwald J, Carlson AL, et al
    Mesenchymal stem cell-neural progenitors are enriched in cell signaling molecules implicated in their therapeutic effect in multiple sclerosis.
    PLoS One. 2023;18:e0290069.
    PubMed     Abstract available
    
    
    
75. POLICK CS, Ploutz-Snyder R, Braley TJ, Connell CM, et al
    Fatigue, pain interference, and psychiatric morbidity in multiple sclerosis: The role of childhood stress.
    PLoS One. 2023;18:e0292233.
    PubMed     Abstract available
    
    
    
76. WOCHATZ M, Schraplau A, Engel T, Zecher MM, et al
    Correction: Application of eccentric training in various clinical populations: Protocol for a multi-centered pilot and feasibility study in people with low back pain and people with multiple sclerosis.
    PLoS One. 2023;18:e0293225.
    PubMed     Abstract available
    
    
    
77. O'MALLEY N, Coote S, Staunton FM, O'Connor E, et al
    A core outcome set for evaluating the effectiveness of mixed-diagnosis falls prevention interventions for people with Multiple Sclerosis, Parkinson's Disease and stroke.
    PLoS One. 2023;18:e0294193.
    PubMed     Abstract available
    
    
    
78. KRAKENES T, Wergeland S, Al-Sharabi N, Mohamed-Ahmed S, et al
    The neuroprotective potential of mesenchymal stem cells from bone marrow and human exfoliated deciduous teeth in a murine model of demyelination.
    PLoS One. 2023;18:e0293908.
    PubMed     Abstract available
    
    
    
79. WILF-YARKONI A, Feldmann K, Rubarth K, Dorsch EM, et al
    Effectiveness of oral prednisone tapering following intravenous methylprednisolone for acute optic neuritis in multiple sclerosis.
    PLoS One. 2023;18:e0288366.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Multiple Sclerosis is free of charge.